Dilution profile // every instrument, one screen, from SEC filings

Cellebrite DI Ltd. (CLBT)

CIK 1854587 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
HIGHF-1 on file 2021-09-27
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
LOWwarrants = 4% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
LOW+28% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
LOWoperating cash flow positive
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2022-03-112026-02-23

Latest: 249.4M shares as of Feb 23, 2026 (20-F).

Cash runway

Self-funding

profitable · generates cash

Full breakdown: cash runway tool

Warrants

Warrants outstanding: 9.7M underlying shares, as reported Jun 30, 2024 (6-K).

Reported exercise price: $0.1 (aggregate figure as tagged; individual tranches vary).

Balance-sheet fair value of warrants: $11 as of Dec 31, 2025.

Rough fully diluted estimate: 259.1M = 249.4M O/S + 9.7M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

The latest 10-Q/10-K instance document could not be checked just now, so nothing is shown rather than guessed. Try again shortly.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding249.4MFeb 23, 2026
+ Warrants (aggregate, as tagged) (if exercised)9.7MJun 30, 2024
Fully diluted estimate259.1M+3.9% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

Last 12 months: 0 executed · 0 registered.

UPDATESep 22, 2022Prospectus update — often a resale registration, not necessarily new capital424B3
EFFECTIVESep 21, 2022SEC declared a registration effective — selling can beginEFFECT
UPDATEAug 11, 2022Prospectus update — often a resale registration, not necessarily new capital424B3
UPDATEMay 12, 2022Prospectus update — often a resale registration, not necessarily new capital424B3
UPDATEApr 15, 2022Prospectus update — often a resale registration, not necessarily new capital424B3
UPDATEApr 6, 2022Prospectus update — often a resale registration, not necessarily new capital424B3
EFFECTIVEApr 5, 2022SEC declared a registration effective — selling can beginEFFECT
UPDATEFeb 16, 2022Prospectus update — often a resale registration, not necessarily new capital424B3
UPDATENov 12, 2021Prospectus update — often a resale registration, not necessarily new capital424B3
UPDATEOct 7, 2021Prospectus update — often a resale registration, not necessarily new capital424B3
EFFECTIVEOct 6, 2021SEC declared a registration effective — selling can beginEFFECT
REGISTEREDSep 27, 2021F-1 registration — capacity to sell shares, not a sale yetF-1

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full CLBT workspace